Qube Research & Technologies (QRT)
TERN

Qube Research & Technologies (QRT)’s Terns Pharmaceuticals TERN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-537,884
Closed -$28.4M – 4071
2026
Q1 		$28.4M Buy
537,884
+530,220
+6,918% +$21.8M 0.03% 683
2025
Q4 		$310K Sell
7,664
-69,118
-90% -$1.6M ﹤0.01% 2943
2025
Q3 		$577K Sell
76,782
-259,883
-77% -$1.66M ﹤0.01% 2683
2025
Q2 		$1.26M Sell
336,665
-358,494
-52% -$1.12M ﹤0.01% 2379
2025
Q1 		$1.92M Buy
695,159
+380,770
+121% +$1.55M ﹤0.01% 1971
2024
Q4 		$1.74M Sell
314,389
-142,550
-31% -$965K ﹤0.01% 1941
2024
Q3 		$3.81M Buy
+456,939
New +$3.76M 0.01% 1520
2023
Q2 		– Sell
-50,951
Closed -$603K – 3003
2023
Q1 		$603K Buy
50,951
+40,406
+383% +$386K ﹤0.01% 1497
2022
Q4 		$107K Sell
10,545
-264
-2% -$1.76K ﹤0.01% 1991
2022
Q3 		$64K Sell
10,809
-599
-5% -$2.23K ﹤0.01% 2084
2022
Q2 		$28K Buy
+11,408
New +$22.8K ﹤0.01% 2218

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TERN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 537,884 shares — an estimated $28.4M sold.

Qube Research & Technologies (QRT) first reported a position in TERN in Q2 2022 and held it in 11 quarters. The position peaked at $28.4M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 537,884 Terns Pharmaceuticals shares in Q2 2026, an estimated $28.4M.
  • Qube Research & Technologies (QRT) first reported a position in Terns Pharmaceuticals in Q2 2022 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Terns Pharmaceuticals position peaked at $28.4M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.